HBA Woman of the Year
In an annual exclusive, Pharm Exec profiles the 2012 Healthcare Businesswomen Association’s Woman of the Year: Carolyn Buck Luce, practice leader in life sciences for Ernst & Young. We trace her rise in the corporate ranks and analyze the latest trends in industry efforts to attract —and keep—the best in female talent for the C-suite.

9th Annual Ad Stars
Pharm Exec selects the best-in-class industry marketing and promotional campaigns for 2012. The standouts are distinguished by refusing to stand pat, with novel and attention-getting strategies prevailing in an increasingly crowded media space.

M&A Outlook
Pharm Exec conducts its annual review of “what the data shows” in industry merger and acquisition trends for 2012. Competition for the best deals remains tight, but financial purse strings are
opening up —for the right deal.

India’s Science Guru
Continuing its coverage of leaders who are making the emerging markets a symbol of alternative paths to biomedical innovation, Pharm Exec offers a profile of India’s R.A. Mashelkar, who advocates a new business model built around the concept of “value for many.”

Surviving—and Thriving—in the New Era of Information Overload
Our editors will explore the emergence of IT as a strategic necessity, covering new technology offerings, trends in analytics, and how to transform information into useful evidence to drive commercial priorities.